Top analysts on stock perps · Analyst
Christopher Pasquale (Barclays): analyst track record on stock perps
Christopher Pasquale of Barclays on companies with stock perpetual futures: star rating, success rate, price-target accuracy, current calls and the measured perp reaction after each rating.
Stars4.2★
Success60%
Excess return+9.7%
rank#1,894
Ratings136
ratings on stock perps10
Track record
TipRanks data via FMPAfter buy calls: not enough measured cases yet
Current calls on stock perps
| Stock | Call | Target | vs last close | Date |
|---|---|---|---|---|
| $ABT Abbott Laboratories | Buy · Maintained | $120 | +21.5% | Oct 22, 2026 |
| $ISRG Intuitive Surgical, Inc. | Buy · Maintained | $500 | +16.9% | Oct 21, 2026 |
| $SYK Stryker Corporation | Buy · Maintained | $375 | +27.4% | Oct 13, 2026 |
| $BSX Boston Scientific Corporation | Hold · Initiated | $48.00 | +7.6% | Oct 7, 2026 |
| $DXCM DexCom, Inc. | Buy · Initiated | $115 | +43.3% | Oct 7, 2026 |
| $MDT Medtronic | Hold · Initiated | $95.00 | +2.1% | Oct 6, 2026 |
Recent ratings
- Oct 22, 2026 $ABT: Maintained · Buy · $120 · article
- Oct 21, 2026 $ISRG: Maintained · Buy · $500 · article
- Oct 13, 2026 $SYK: Maintained · Buy · $375 · article
- Oct 7, 2026 $ISRG: Initiated · Buy · $485 · article
- Oct 7, 2026 $DXCM: Initiated · Buy · $115 · article
- Oct 7, 2026 $BSX: Initiated · Hold · $48.00 · article
- Oct 7, 2026 $SYK: Initiated · Buy · $375 · article
- Oct 6, 2026 $MDT: Initiated · Hold · $95.00 · article
- Apr 23, 2026 $BSX: Upgraded · Buy · $85.00 · article
- Dec 8, 2025 $MDT: Upgraded · Buy · $120 · article
Christopher Pasquale4.2★ · 60% success · +9.7% excess return · TipRanks data via FMP · Source headlines via TheFly/StreetInsider (FMP). Reaction = venue-median perp move after our detection — an observation, not investment advice.